VBI Vaccines Inc

Call
Website

Photos

160 2nd St Ste 3
Cambridge, MA 02141
+1 (617) 830-3031
https://www.vbivaccines.com
Since its establishment in 1970, the Paulson Investment Company has carved out a strong position as one of the leading investment bankers that specializes in small and emerging growth opportunities with capital needs from $5 million to $40 million. As one of the country s most active SmallCap investment bankers, Paulson works with some of the most successful entrepreneurs. The company is also one of the largest independent brokerage firms and is one of the leading investment bankers for emerging companies nationwide. Paulson offers a range of investment vehicles and insight into emerging business opportunities, online services and responsive support from broker to back office. The Paulson Investment Company maintains offices in Portland, Ore.
Own this business?
See a problem?

You might also like

Drugs acting on the respiratory system, Blood derivatives

C4T Securities Corporation

C4 Therapeutics, Inc. is a biotechnology company based in Watertown, MA, specializing in targeted protein degradation. Their innovative approach, known as Targeted Protein Degradation (TPD), aims to develop a new generation of medicines for treating various diseases. Through their TORPEDO platform and focus on target selection, C4 Therapeutics is dedicated to transforming lives by degrading disease-causing proteins. With a strong leadership team, board of directors, and scientific advisory board, C4 Therapeutics is committed to advancing their pipeline of therapies, including CFT7455, CFT1946, and CFT8919. They also collaborate with industry partners such as Roche, Biogen, Betta Merck, and others to further their research and development efforts. At C4 Therapeutics, their values, people, and dedication to scientific progress drive their mission to revolutionize the treatment of diseases through targeted protein degradation.Generated from the website
Medical research, Biotechnical research, noncommercial, Blood derivatives

Nabsys Inc

Nabsys Inc, a leading innovator in electronic whole-genome mapping, offers precise analysis of genomic structural data with remarkable cost efficiency. The company's cutting-edge technology provides comprehensive insights into genetic information, revolutionizing the field of genomics. Generated from their website's infomation
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
United States›Massachusetts›Cambridge›VBI Vaccines Inc

Partial Data by Infogroup (c) 2025. All rights reserved.